Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Rapid Tumor Debulking of Relapsed/Refractory CLL Patients By PI3Kδ Inhibition and Anti-CD20 Monoclonal Antibody Treatment

Jennifer E. Bruno, Christine A. Herne, Andrea M Baran, Karl R. VanDerMeid, Paul M. Barr, Alyssa R. Williams, Sally A. Quataert, Clive S. Zent, Charles C. Chu

Blood (2022) 140 (Supplement 1): 4121–4122.

https://doi.org/10.1182/blood-2022-169403

Published: 2022

Journal Articles

Real-World Applicability of Commercial Chimeric Antigen Receptor T Cell Therapy Among Older Adults with Relapsed and/or Refractory Multiple Myeloma

Smith Giri, Susan Bal, Kelly N. Godby, Gayathri Ravi, Deanna Clark, Clare Ubersax, Abigail Cooley, Priscila White, Sunil Rangarajan, Grant R Williams, Luciano J. Costa

Blood (2021) 138 (Supplement 1): 4107.

https://doi.org/10.1182/blood-2021-153796

Published: 2021

Journal Articles

Phase II Study of Acalabrutinib and High-Frequency Low-Dose Subcutaneous Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Danielle S. Wallace, Andrea M. Baran, Jonathan W. Friedberg, Patrick M. Reagan, Carla Casulo, Mijamin Friend, Alyssa R. Williams, Peter D Dakin, Clive S. Zent, Paul M. Barr

Blood (2021) 138 (Supplement 1): 2640.

https://doi.org/10.1182/blood-2021-145490

Published: 2021

Journal Articles

Practice Patterns and Predictors of Severe Toxicity Among Older Adults with Diffuse Large B Cell Lymphoma Treated with Frontline Chemoimmunotherapy

Star Ye, Mayur Narkhede, Sean Patrick Bliven, Gaurav Goyal, Amitkumar Mehta, Christian Harmon, Deanna Clark, Clare Ubersax, Sunil Rangarajan, Grant R Williams, Smith Giri

Blood (2021) 138 (Supplement 1): 1435.

https://doi.org/10.1182/blood-2021-151211

Published: 2021

Journal Articles

Multiple Myeloma (MM) in the Very Old: Disease Characteristics, Treatment Patterns and Outcomes in the Real World

Smith Giri, MDMS, Susan Bal, MDMBBS, Kelly N. Godby, MD, Grant R Williams, Luciano J. Costa, MD PhD, Smita Bhatia, MDMPH

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-143223

Published: 2020

Journal Articles

Role of Neutrophil Lymphocyte Ratio [NLR] As a Biomarker of Frailty and Predictor of Survival Among Older Adults with Multiple Myeloma (MM)

Smith Giri, MDMS, Susan Bal, MDMBBS, Kelly N. Godby, MD, Joshua Richman, MD PhD, Adam J Olszewski, MD, Grant R Williams, Luciano J. Costa, MD PhD, Smita Bhatia, MDMPH

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-143290

Published: 2020

Journal Articles

Health Care and out-of-Pocket (OOP) Costs Among Medicare Beneficiaries Diagnosed with Chronic Myeloid Leukemia (CML)

Kelly Kenzik, PhD, Ravi Bhatia, MD, Grant R Williams, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2018-99-110742

Published: 2018

Journal Articles

Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)

Kathleen Maignan, NP, Daniel Backenroth, Neil A. McQuarrie, Nicole G. Lipitz, Erin R. Williams, Kenneth R. Carson

Blood (2018) 132 (Supplement 1): 4734.

https://doi.org/10.1182/blood-2018-99-112153

Published: 2018

Journal Articles

Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity

Allegra A Petti, PhD, Stephen R Williams, PhD, Christopher A Miller, PhD, Ian T Fiddes, PhD, David Chen, MD PhD, Sridhar Nonavinkere Srivatsan, MS, Catrina Fronick, BS, Robert Fulton, MS, Deanna M Church, PhD, Timothy J Ley, MD

Blood (2018) 132 (Supplement 1): 1314.

https://doi.org/10.1182/blood-2018-99-119075

Published: 2018

Journal Articles

Chronic Severe Pain and Use of Prescription Pain Medications in Older Survivors of Hematologic Malignancies (HM) Several Years after Treatment with Blood or Marrow Transplantation (BMT): A Report from BMTSS

Naveed Farrukh, Lindsey Hageman, MPH, Yanjun Chen, MS, Jessica Wu, MPH, Emily Ness, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Wendy Landier, PhD CRNP, Mukta Arora, MD, Saro H. Armenian, DO, MPH, Grant R Williams, Smita Bhatia, MD MPH

Blood (2018) 132 (Supplement 1): 715.

https://doi.org/10.1182/blood-2018-99-111500

Published: 2018

Journal Articles

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

Blood (2017) 129 (26): 3452–3464.

https://doi.org/10.1182/blood-2017-03-773341

Published: 2017

Includes: Supplemental data

Journal Articles

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification

Owen W. Stephens, Qing Zhang, Pingping Qu, Yiming Zhou, Shweta Chavan, Erming Tian, David R. Williams, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2012) 119 (2): 503–512.

https://doi.org/10.1182/blood-2011-07-367052

Published: 2012

Includes: Supplemental data

Journal Articles

p90RSK2 is essential for FLT3-ITD– but dispensable for BCR-ABL–induced myeloid leukemia

Shannon Elf, Dean Blevins, Lingtao Jin, Tae-Wook Chung, Ifor R. Williams, Benjamin H. Lee, Jian-Xin Lin, Warren J. Leonard, Jack Taunton, Hanna J. Khoury, Sumin Kang

Blood (2011) 117 (25): 6885–6894.

https://doi.org/10.1182/blood-2010-10-315721

Published: 2011

Includes: Supplemental data

Journal Articles

Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties

Maximilien Vanleene, Zahraa Saldanha, Kristy L. Cloyd, Gavin Jell, George Bou-Gharios, J. H. Duncan Bassett, Graham R. Williams, Nicholas M. Fisk, Michelle L. Oyen, Molly M. Stevens, Pascale V. Guillot, Sandra J. Shefelbine

Blood (2011) 117 (3): 1053–1060.

https://doi.org/10.1182/blood-2010-05-287565

Published: 2011

Includes: Supplemental data

Journal Articles

Myeloma Cell Interaction with Mesenchymal Stem Cells: Heterogeneity of Myeloma Cell Survival and Gene Expression Studies

Igor Entin, PhD, Damir Herman, PhD, David R. Williams, John Freeman, John D Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc

Blood (2008) 112 (11): 2738.

https://doi.org/10.1182/blood.V112.11.2738.2738

Published: 2008

Journal Articles

Expression of Myeloma-Specific Markers in Bone Marrow Spicules Using a Novel Immunohistochemical Technique

Madhumita Santra, John Shaughnessy, David R. Williams, Bart Barlogie, William Bellamy

Blood (2008) 112 (11): 5152.

https://doi.org/10.1182/blood.V112.11.5152.5152

Published: 2008

Journal Articles

Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice

Pascale V. Guillot, Oyebode Abass, J. H. Duncan Bassett, Sandra J. Shefelbine, George Bou-Gharios, Jerry Chan, Hitoshi Kurata, Graham R. Williams, Julia Polak, Nicholas M. Fisk

Blood (2008) 111 (3): 1717–1725.

https://doi.org/10.1182/blood-2007-08-105809

Published: 2008

Journal Articles

LBH589, a Novel Deacetylase Inhibitor (DACi), Treatment of Patients with Cutaneous T-Cell Lymphoma (CTCL). Skin Gene Expression Profiles in the First 24 Hours Related to Clinical Response Following Therapy.

Miles Prince, MBBS, D.J. George, MD, R. Johnstone, PhD, C. McCormack, MBBS, L. Ellis, PhD, R. Williams-Truax, P. Atadja, PhD, C. Zhao, MD, M. Dugan, MD, K. Culver, MD

Blood (2006) 108 (11): 2715.

https://doi.org/10.1182/blood.V108.11.2715.2715

Published: 2006

Journal Articles

FoxO Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress.

Zuzana Tothova, Ramya Kollipara, Brian J. Huntly, Benjamin H. Lee, Diego H. Castrillon, Emmanuelle A. Passegue, Dana E. Cullen, Elizabeth P. McDowell, Suzan Lazo-Kallanian, Ifor R. Williams, Ronald A. DePinho, D. Gary Gilliland

Blood (2006) 108 (11): 439.

https://doi.org/10.1182/blood.V108.11.439.439

Published: 2006

Journal Articles

Ott1(Rbm15) Is Essential for Pre-B Differentiation and Has an Inhibitory Role in Myeloid and Megakaryocytic Lineages.

Glen D. Raffel, MD, PhD, Thomas Mercher, Ph.D., Hirokazu Shigematsu, M.D., Ifor R. Williams, M.D., Ph.D., Dana E. Cullen, Koichi Akashi, M.D., Ph.D., Olivier A. Bernard, Ph.D., D. Gary Gilliland, M.D., Ph.D.

Blood (2006) 108 (11): 784.

https://doi.org/10.1182/blood.V108.11.784.784

Published: 2006

NARROW

Rapid Tumor Debulking of Relapsed/Refractory CLL Patients By PI3Kδ Inhibition and Anti-CD20 Monoclonal Antibody Treatment

Real-World Applicability of Commercial Chimeric Antigen Receptor T Cell Therapy Among Older Adults with Relapsed and/or Refractory Multiple Myeloma

Phase II Study of Acalabrutinib and High-Frequency Low-Dose Subcutaneous Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Practice Patterns and Predictors of Severe Toxicity Among Older Adults with Diffuse Large B Cell Lymphoma Treated with Frontline Chemoimmunotherapy

Multiple Myeloma (MM) in the Very Old: Disease Characteristics, Treatment Patterns and Outcomes in the Real World

Role of Neutrophil Lymphocyte Ratio [NLR] As a Biomarker of Frailty and Predictor of Survival Among Older Adults with Multiple Myeloma (MM)

Health Care and out-of-Pocket (OOP) Costs Among Medicare Beneficiaries Diagnosed with Chronic Myeloid Leukemia (CML)

Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)

Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity

Chronic Severe Pain and Use of Prescription Pain Medications in Older Survivors of Hematologic Malignancies (HM) Several Years after Treatment with Blood or Marrow Transplantation (BMT): A Report from BMTSS

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification

p90RSK2 is essential for FLT3-ITD– but dispensable for BCR-ABL–induced myeloid leukemia

Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties

Myeloma Cell Interaction with Mesenchymal Stem Cells: Heterogeneity of Myeloma Cell Survival and Gene Expression Studies

Expression of Myeloma-Specific Markers in Bone Marrow Spicules Using a Novel Immunohistochemical Technique

Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice

LBH589, a Novel Deacetylase Inhibitor (DACi), Treatment of Patients with Cutaneous T-Cell Lymphoma (CTCL). Skin Gene Expression Profiles in the First 24 Hours Related to Clinical Response Following Therapy.

FoxO Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress.

Ott1(Rbm15) Is Essential for Pre-B Differentiation and Has an Inhibitory Role in Myeloid and Megakaryocytic Lineages.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only